Technical Analysis for MDP - Medexus Pharmaceuticals Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Bullish Engulfing | Bullish | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
BB Squeeze + Lower Band Touch | Range Contraction | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 2.65% | |
NR7 | Range Contraction | 2.65% | |
Stochastic Reached Oversold | Weakness | 2.65% | |
Down 3 Days in a Row | Weakness | 2.65% | |
Oversold Stochastic | Weakness | 2.65% |
Get a Trading Assistant
- Earnings date: 2024-02-01
Medexus Pharmaceuticals Inc. Description
Medexus Pharmaceuticals Inc, formerly Pediapharm Inc, is a Canada-based company engaged in pharmaceutical business sector. The Company is a North American focused, specialty pharmaceutical business that operates through three segments: Medac Pharma USA, a fully integrated commercial infrastructure focused on auto-immune diseases in the United States; Medexus Pharma Canada, a fully integrated commercial infrastructure focused on auto-immune disease and pediatric diseases in Canada; and a Business Development function, which works to maintain its product pipeline. The Company's flag products are Rasuvo and Metoject, a formulation of methotrexate (auto-pen and pre-filled syringe) designed to treat rheumatoid arthritis and other auto-immune diseases; and Rupall, an allergy medication. The Company provides products for the healthcare professionals and patients.
Classification
Keywords: Health Infrastructure Healthcare Pharma Pipe Pharmaceutical Integrated Pipeline Disease Drugs Pharmaceuticals Diseases Arthritis Medication Cnx Nifty Pharmaceutical Business Sector Pharmaceutical Industry In China Rheumatoid Arthritis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 3.53 |
52 Week Low | 1.12 |
Average Volume | 55,112 |
200-Day Moving Average | 2.211 |
50-Day Moving Average | 1.678 |
20-Day Moving Average | 1.586 |
10-Day Moving Average | 1.562 |
Average True Range | 0.096 |
RSI (14) | 43.50 |
ADX | 14.43 |
+DI | 13.424 |
-DI | 20.418 |
Chandelier Exit (Long, 3 ATRs) | 1.471 |
Chandelier Exit (Short, 3 ATRs) | 1.759 |
Upper Bollinger Bands | 1.698 |
Lower Bollinger Band | 1.474 |
Percent B (%b) | 0.34 |
BandWidth | 14.136 |
MACD Line | -0.046 |
MACD Signal Line | -0.051 |
MACD Histogram | 0.0051 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.670 | ||||
Resistance 3 (R3) | 1.657 | 1.603 | 1.650 | ||
Resistance 2 (R2) | 1.603 | 1.573 | 1.610 | 1.643 | |
Resistance 1 (R1) | 1.577 | 1.554 | 1.590 | 1.590 | 1.637 |
Pivot Point | 1.523 | 1.523 | 1.530 | 1.530 | 1.523 |
Support 1 (S1) | 1.497 | 1.493 | 1.510 | 1.510 | 1.463 |
Support 2 (S2) | 1.443 | 1.474 | 1.450 | 1.457 | |
Support 3 (S3) | 1.417 | 1.443 | 1.450 | ||
Support 4 (S4) | 1.430 |